Mirk/Dyrk1B Kinase Inhibitors in Targeted Cancer Therapy
N Kokkorakis, M Zouridakis, M Gaitanou - Pharmaceutics, 2024 - mdpi.com
During the last years, there has been an increased effort in the discovery of selective and
potent kinase inhibitors for targeted cancer therapy. Kinase inhibitors exhibit less toxicity …
potent kinase inhibitors for targeted cancer therapy. Kinase inhibitors exhibit less toxicity …
Curcumin Inhibition of DYRK Kinases
F Menezes, P Grygier, K Pustelny, GM Popowicz… - bioRxiv, 2024 - biorxiv.org
Curcumin is known as a dietary supplement with several health benefits, including
antioxidant, blood sugar-lowering, anti-inflammatory, and anti-cancer properties. These …
antioxidant, blood sugar-lowering, anti-inflammatory, and anti-cancer properties. These …